BackgroundBecause of their individual rarity, genetic diseases and other types of rare diseases are under-represented in healthcare coding systems; this contributes to a lack of ascertainment and recognition of their importance for healthcare planning and resource allocation, and prevents clinical research from being performed.MethodsOrphanet was given the task to develop an inventory of rare diseases and a classification system which could serve as a template to update International terminologies. When the World Health Organization (WHO) launched the revision process of the International Classification of Diseases (ICD), a Topic Advisory Group for rare diseases was established, managed by Orphanet and funded by the European Commission.ResultsSo far 5,400 rare diseases listed in the Orphanet database have an endorsed representation in the foundation layer of ICD-11, and are thus provided with a unique identifier in the Beta version of ICD-11, which is 10 times more than in ICD10. A rare disease linearization is also planned. The current beta version is open for public consultation and comments, and to be used for field testing. The adoption by the World Health Assembly is planned for 2017.ConclusionsThe overall revision process was carried out with very limited means considering its scope, ambition and strategic significance, and experienced significant hurdles and setbacks. The lack of funding impacted the level of professionalism that could be attained. The contrast between the initially declared goals and the currently foreseen final product is disappointing. In the context of uncertainty around the outcome of the field testing and the potential willingness of countries to adopt this new version, the European Commission Expert Group on Rare Diseases adopted in November 2014 a recommendation for health care coding systems to consider using ORPHA codes in addition to ICD10 codes for rare diseases having no specific ICD10 codes. The Orphanet terminology, classifications and mappings with other terminologies are freely available at www.orphadata.org.
[1]
P Demoly,et al.
Global classification and coding of hypersensitivity diseases – An EAACI – WAO survey, strategic paper and review
,
2014,
Allergy.
[2]
Olivier Bodenreider,et al.
A Content Model for the ICD-11 Revision
,
2010
.
[3]
François Schiettecatte,et al.
OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders
,
2014,
Nucleic Acids Res..
[4]
F. Dhombres,et al.
Representation of rare diseases in health information systems: The orphanet approach to serve a wide range of end users
,
2012,
Human mutation.
[5]
Csongor Nyulas,et al.
Supporting the Collaborative Authoring of ICD-11 with WebProtégé.
,
2010,
AMIA ... Annual Symposium proceedings. AMIA Symposium.
[6]
Maja Milicic Brandt,et al.
Mapping Orphanet Terminology to UMLS
,
2011,
AIME.
[7]
Leslie G Biesecker,et al.
Next‐generation sequencing demands next‐generation phenotyping
,
2012,
Human mutation.
[8]
Monica Mazzucato,et al.
A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region’s rare diseases registry
,
2014,
Orphanet Journal of Rare Diseases.
[9]
C G Chute.
Distributed biomedical terminology development: from experiments to open process.
,
2010,
Yearbook of medical informatics.
[10]
The classification of neurological disorders in the 11th revision of the International Classification of Diseases (ICD-11)
,
2013,
Journal of Neurology, Neurosurgery & Psychiatry.